Bio-Polyamide Market Share, Size, Growth and Forecast By 2026.

 

The latest report by IMARC Group, titled “Bio-Polyamide Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” finds that the global bio-polyamide market reached a value of US$ 168.3 Million in 2020. Bio-polyamide is a synthesized polymer derived from bio-based or renewable raw materials such as natural fats and oils. It exhibits properties of renewability, recyclability, lightweight, and non-abrasiveness. It is also environmentally friendly and cost-effective, with excellent mechanical and thermal performance, low moisture absorption, and strong chemical resistance. As a result, bio-polyamide find application in automotive fuel line, pneumatic air brake tubing, electrical cable jacketing, powder coatings, and flexible and gas pipes. Nowadays, it is also used to manufacture sporting goods, electronic casings, toothbrushes, and carpets.



Request for a PDF sample of this report: https://www.imarcgroup.com/bio-polyamide-market/requestsample

Global Bio-Polyamide Market Trends: 

The market is primarily driven by the growing preference for eco-friendly and sustainable solutions across various industries. The significant expansion of the automobile, electrical and electronics, and textile sectors are fueling the growth of the bio-polyamide market. In the automotive industry, bio-polyamide is used to manufacture automotive parts like gears, bushings, and plastic bearings. In addition, the excellent processability, high mechanical strength, and thermal performance of bio-polyamide are also increasing its adoption in high-performance applications including, marine and electronic industries. Besides this, the growing demand for eco-friendly polymers that are synthesized from renewable raw materials and help reduce greenhouse emissions are significantly influencing the market growth. Furthermore, stringent regulations imposed by governments of various countries to control carbon emissions have resulted in the development of lightweight vehicles, thereby creating a positive outlook for the market. Looking forward, the market is expected to grow at a CAGR of 11.8% during the forecast period (2021-2026).

Checkout Now: https://www.imarcgroup.com/checkout?id=2073&method=1

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

 

Market Summary: 

·      Based on the product type, the market has been segmented into PA-6, PA-66, and others. Currently, PA-6 represents the most popular product type.  

·      On the basis of the application, the market has been classified into industrial plastics and fibers. Among these, industrial plastics accounts for the majority of the total market share.

·      The market has been categorized based on the end use into automotive, textiles and sports, industrial goods, films and coatings, electrical and electronics, and others. Currently the automotive sector holds the largest market share.

·      Region-wise, the market has been divided into Europe, North America, Asia Pacific, Middle East and Africa, and Latin America. Amongst these, Asia Pacific exhibits a clear dominance in the global market.

·      The competitive landscape of the market has been examined, with some of the key players being Arkema Group, Asahi Kasei Corporation, BASF SE, Koninklijke DSM N.V., Evonik Industries AG, Domo Chemicals GmbH, Lanxess AG, Saudi Basic Industries Corporation (SABIC), Solvay S.A., and Simona AG.


Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://bit.ly/3L2Ztbj

Note: We are updating our reports, If you want the report with the latest primary and secondary data (2021-2026) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Key highlights of the report:

  • Market Performance (2015-2020)
  • Market Outlook (2021-2026)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

 

 

 

Comments

Post a Comment

Popular posts from this blog

Outsourcing in Banking: Enhancing Efficiency and Addressing Risks

Image
Outsourcing in the banking sector has become a crucial strategy for streamlining products and services, optimizing resource management, reducing costs, and ultimately delivering greater value to customers. As financial institutions navigate a complex regulatory landscape, they are increasingly focusing on their core activities and looking for ways to enhance operational efficiency. The Need for Cost Optimization Banks face various challenges, including capital requirements, financial reporting, and corporate governance standards. Many institutions have shifted their attention from global capital markets to concentrate on their fundamental banking operations. This shift is essential not only for compliance but also for maintaining competitiveness in a market where operating costs significantly impact the pricing of financial products. To remain competitive, banks must find ways to lower their operational costs without compromising service quality. This is where outsourcing comes into pl...
Read more

North America Frozen Seafood Market: Industry Overview, Growth, Trends, Opportunities and Forecast Till 2026

Image
 According to IMARC Group’s latest report, titled “ North America Frozen Seafood Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 ”, the North America frozen seafood market reached a value of US$ 13.4 Billion in 2020. Frozen seafood products are preserved for inhibiting the growth of bacteria in order to increase their shelf life, taste, and nutritional value. The seafood freezing technique includes two different approaches, namely, cryofreezing and carboxymethylcellulose. In cryofreezing, seafood items, such as salmon, tuna, shrimp, oysters, and tilapia, are kept in ultra-low liquid nitrogen for maintaining their quality. On the other hand, carboxymethylcellulose is used to curb the adulteration of seafood commodities. We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report. Request for a PDF sample of this report : https...
Read more

Biosimilar Market Size 2022-27: Trends, Share, Growth, Opportunity and Forecast

Image
According to the recent report by IMARC Group, entitled “ Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027 ”, the  global biosimilar market size was estimated to be US$ 13.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 60.8 Billion by 2027, exhibiting at a CAGR of 26.1% during 2022-2027. Biosimilars, also known as subsequent entry biologics (SEBs) or follow-on biologics, refer to FDA-approved biotherapeutic products which are similar to their reference biologics. Biosimilars can only be manufactured after the patent of the reference product expires. The demand for biosimilars has been increasing in recent years as they help in reducing the overall cost of the treatment for a variety of chronic diseases including cancers, autoimmune diseases, kidney failure, diabetes, CVDs, haematological disorders, infectious diseases, rheumatoid arthritis, growth hormone deficiency, etc. We are regularly track...
Read more